Low performance of sinovac vaccine particularly with belatacept therapy in a study with different types of COVID-19 vaccines in transplanted patientstaged
The huge impact of SARS-CoV-2 infections on organ transplant recipients makes it necessary to optimize vaccine efficacy in this population. To effectively implement multiple strategies, it is crucial to understand the performance of each type of available vaccine. In our study, the antibody titer wa...
- Autores:
-
Arias Murillo, Yazmin Rocio
Salinas Nova, Maria Angelica
Caicedo, Tatiana
Galindo-Borda, Marisol
Meneses-Gil, Ximena
Montero, Camilo
Giron, Fernando
Pedraza, Nestor
Aroca-Martinez, Gustavo
Ospina-Martínez, Martha Lucía
Mercado-Reyes, Marcela
- Tipo de recurso:
- Fecha de publicación:
- 2024
- Institución:
- Universidad Simón Bolívar
- Repositorio:
- Repositorio Digital USB
- Idioma:
- eng
- OAI Identifier:
- oai:bonga.unisimon.edu.co:20.500.12442/15724
- Acceso en línea:
- https://hdl.handle.net/20.500.12442/15724
https://doi.org/10.1016/j.transproceed.2023.02.034
https://www.sciencedirect.com/science/article/pii/S0041134523000696?via%3Dihub
- Palabra clave:
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivs 3.0 United States